I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| macrophage | 21 studies | 40% ± 22% | |
| astrocyte | 19 studies | 48% ± 20% | |
| endothelial cell | 18 studies | 34% ± 17% | |
| microglial cell | 16 studies | 76% ± 20% | |
| oligodendrocyte | 13 studies | 29% ± 13% | |
| myeloid cell | 9 studies | 38% ± 17% | |
| glutamatergic neuron | 8 studies | 34% ± 19% | |
| dendritic cell | 8 studies | 29% ± 14% | |
| GABAergic neuron | 7 studies | 43% ± 16% | |
| T cell | 7 studies | 30% ± 9% | |
| fibroblast | 6 studies | 27% ± 8% | |
| non-classical monocyte | 5 studies | 22% ± 10% | |
| interneuron | 5 studies | 40% ± 10% | |
| CD16-negative, CD56-bright natural killer cell, human | 5 studies | 33% ± 19% | |
| cardiac muscle cell | 5 studies | 31% ± 9% | |
| endothelial cell of lymphatic vessel | 5 studies | 25% ± 6% | |
| natural killer cell | 5 studies | 38% ± 14% | |
| epithelial cell | 4 studies | 24% ± 7% | |
| granule cell | 4 studies | 28% ± 6% | |
| oligodendrocyte precursor cell | 4 studies | 24% ± 8% | |
| plasma cell | 4 studies | 44% ± 14% | |
| CD4-positive, alpha-beta T cell | 4 studies | 35% ± 11% | |
| CD8-positive, alpha-beta T cell | 4 studies | 36% ± 15% | |
| lymphocyte | 4 studies | 47% ± 19% | |
| Mueller cell | 4 studies | 55% ± 17% | |
| amacrine cell | 4 studies | 55% ± 14% | |
| retinal cone cell | 4 studies | 73% ± 21% | |
| monocyte | 4 studies | 33% ± 8% | |
| smooth muscle cell | 4 studies | 20% ± 3% | |
| GABAergic interneuron | 3 studies | 33% ± 12% | |
| neuron | 3 studies | 37% ± 8% | |
| mononuclear phagocyte | 3 studies | 24% ± 5% | |
| GABAergic amacrine cell | 3 studies | 37% ± 10% | |
| glycinergic amacrine cell | 3 studies | 34% ± 3% | |
| retinal rod cell | 3 studies | 72% ± 6% | |
| endothelial cell of vascular tree | 3 studies | 30% ± 17% | |
| ependymal cell | 3 studies | 58% ± 15% | |
| alveolar macrophage | 3 studies | 46% ± 8% | |
| leukocyte | 3 studies | 79% ± 9% |
